Company Filing History:
Years Active: 2014
Title: An Innovative Approach to Cancer Treatment by Masafumi Kurosumi
Introduction
Masafumi Kurosumi, a dedicated inventor based in Saitama, Japan, has made significant contributions to the field of cancer treatment through his innovative patent. With a focus on creating effective methods for the administration of anti-cancer drugs, Kurosumi's work stands as an important advancement in oncological care.
Latest Patents
Kurosumi holds one patent titled "Method for the administration of anti-cancer drugs." This inventive method involves determining the type of cancer through specific data regarding the Estrogen Receptor (ER) and Human Epidermal growth factor Receptor-2 (Her2). Depending on the results, the method encompasses tailored treatment plans involving docetaxel and a combination of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) to optimize patient response.
Career Highlights
Throughout his career, Masafumi Kurosumi has been associated with the Japan Breast Cancer Research Group, where he has been pivotal in researching and developing effective cancer treatment methodologies. His dedication to enhancing patient outcomes through innovative solutions is reflected in his ongoing work and research endeavors.
Collaborations
Kurosumi collaborates with esteemed colleagues such as Masakazu Toi and Hiroji Iwata, contributing to an environment of innovation and collective expertise. Their combined efforts exemplify the importance of teamwork in tackling complex medical challenges and advancing cancer treatment.
Conclusion
Masafumi Kurosumi's innovative approach to administering anti-cancer drugs exemplifies the critical role that inventors play in enhancing healthcare. His commitment to research and collaboration not only advances medical science but also offers hope to numerous patients battling cancer. As he continues to explore new frontiers in cancer treatment, the impact of his work will undoubtedly resonate within the medical community and beyond.